BAKU, Azerbaijan, Jun. 12
By Nargiz Sadikhova - Trend:
Construction of a biopharmaceutical vaccine manufacturing plant was launched at Research Institute of Biological Safety of the Committee of Sciences of the Ministry of Education and Science in Kazakhstan’s Zhambyl region, Trend reports with reference to the press office of Kazakhstan’s prime minister.
The plant will produce immunobiological drugs, including coronavirus vaccines. Currently, the possible vaccine against COVID-19 developed by Kazakhstan Research Institute is included in the World Health Organization (WHO) list and is successfully undergoing trials.
The plant company will also produce vaccines against influenza, tuberculosis, brucellosis, nodular dermatitis, plague of small ruminants, contagious ectima of sheep and goats, sheep pox, rabies and other infectious diseases.
The construction is to be completed in December 2020.
The Institute of Biological Safety under the Committee on Science of the Ministry of Education and Science of the Republic of Kazakhstan was established in 1958 as one of the six largest virological institutes in the USSR.
The research institute develops vaccines for agriculture and the health care system, produces immunobiological preparations, conducts research in the field of biological safety threats, develops test systems for the diagnosis of dangerous and especially dangerous diseases, and acts as a depository of dangerous and especially dangerous strains of viruses and microorganisms.
---
Follow the author on twitter: @nargiz_sadikh